Baotou Dongbao Bio-Tech Co.,Ltd

SZSE:300239 Stock Report

Market Cap: CN¥3.2b

Baotou Dongbao Bio-TechLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Baotou Dongbao Bio-TechLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth39.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

Oct 08
Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Oct 01
We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

May 27
Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Feb 28
Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Baotou Dongbao Bio-TechLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:300239 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202487391-1798N/A
6/30/2024898106118243N/A
3/31/202495511566212N/A
12/31/202397512067199N/A
9/30/202397211759199N/A
6/30/2023988116-14104N/A
3/31/202397711751148N/A
1/1/202394310987195N/A
9/30/2022906111103153N/A
6/30/202281287111166N/A
3/31/2022702561074N/A
1/1/202261236052N/A
9/30/202156022-2955N/A
6/30/202153919-9838N/A
3/31/202149720-8469N/A
12/31/202044918-8963N/A
9/30/202045420-7347N/A
6/30/202044822-7627N/A
3/31/202046929-180-70N/A
12/31/201949233-172-42N/A
9/30/201947035-171-13N/A
6/30/201945435-127-11N/A
3/31/2019467351595N/A
12/31/201845334560N/A
9/30/201843630-3440N/A
6/30/201842427N/A17N/A
3/31/201837824N/A-6N/A
12/31/201735622N/A-3N/A
9/30/201733022N/A5N/A
6/30/201731823N/A52N/A
3/31/201731422N/A48N/A
12/31/201631719N/A41N/A
9/30/201632014N/A35N/A
6/30/201631110N/A26N/A
3/31/20163057N/A27N/A
12/31/20152926N/A46N/A
9/30/20152797N/A31N/A
6/30/20152755N/A18N/A
3/31/20152604N/A12N/A
12/31/20142515N/A-12N/A
9/30/201425912N/A-26N/A
6/30/201428822N/A-26N/A
3/31/201433831N/A-17N/A
12/31/201338243N/A9N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 300239's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 300239's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 300239's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 300239's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 300239's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300239's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y